2026 NPPES data Infectious Disease Physician NPI 1003813262 M.D.
Verify on CMS →

ABDUL HALAWA, M.D.

Infectious Disease Physician in CHARDON, Ohio. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
249
Medicare Part D claims · 40 beneficiaries · Infectious Disease Physician avg: 816
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$32.48
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ABDUL HALAWA, M.D. is a Infectious Disease Physician ([object Object]) practicing in CHARDON, Ohio with a Medicare Part D prescribing footprint of 249 claims across 40 beneficiaries — 10% brand-name prescribing . Industry payments of $32.48 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ABDUL HALAWA, M.D. filed 249 Medicare Part D claims in 2023 across CHARDON, Ohio. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

ABDUL HALAWA, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

ABDUL HALAWA, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 07/03/2005

NPI 1003813262

Primary specialty

Infectious Disease Physician

Mid-sized

8,292 US NPIs in this specialty

Medicare Part D claims

249 69% vs specialty avg

2023 prescription claims

Specialty avg: 816

Specialty distribution in Ohio

How Infectious Disease Physician compares to other specialties among Ohio providers

Ohio providers

Infectious Disease Physician share within Ohio

1. Infectious Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Infectious Disease Physician share within Ohio

Specialty board-certification context

Estimated specialty board-certified rate — Infectious Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Infectious Disease Physician ABMS/AOA estimate

Est. board-certified rate (Infectious Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Infectious Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ABDUL HALAWA, M.D. is a Infectious Disease Physician provider practicing in CHARDON, Ohio, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1003813262. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ABDUL HALAWA, M.D. appears in the CMS NPPES registry as a Infectious Disease Physician provider holding M.D. credentials at 13170 RAVENNA RD, CHARDON, OH, 44024, with a listed phone of (440) 739-0420. NPI 1003813262 was issued on 07/03/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HALAWA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 249 prescription claims written by this provider, covering 40 Medicare beneficiaries and totaling roughly $15K in drug spend, split 10% brand-name and 90% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Infectious Disease Physician is a mid-sized specialty nationwide, with 8,292 enrolled providers across 54 states and an average of 816 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

13170 RAVENNA RD
CHARDON, OH 44024

Provider Details

NPI 1003813262
Specialty Infectious Disease Physician
Credentials M.D.
Gender Male
NPI Issued 07/03/2005

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ABDUL HALAWA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$32

Largest payer

Insmed, Inc.

Most common payment type

Education

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Ohio OMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 — they are NOT specific to ABDUL HALAWA, M.D.. To verify ABDUL HALAWA, M.D.'s current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases

OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ABDUL HALAWA, M.D. — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 249 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

249
Total Claims
$15K
Total Drug Cost
40
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
313
Total Day Supply
5,697
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$2K
Generic Drug Cost
$13K
Antibiotic Claims
191

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
2.76
Gender Split
45% female / 55% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ceftriaxone
Ceftriaxone Sodium
64
Furosemide
21
Vancomycin Hcl
19
Ampicillin Sodium
17
Cefuroxime
Cefuroxime Axetil
16
Sodium Chloride
0.9 % Sodium Chloride
16
Doxycycline Hyclate
14
Amoxicillin
12
Chlorhexidine Gluconate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Infectious Disease Physician Overview

How ABDUL HALAWA, M.D. fits within the Infectious Disease Physician landscape nationally.

8,292
Infectious Disease Physician Providers in US
54
States with Infectious Disease Physician
816
Avg Claims per Provider

ABDUL HALAWA, M.D.'s 249 claims are below the specialty average of 816.

Nearby Infectious Disease Physician Providers in Ohio

Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as HALAWA.

Compare Infectious Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ABDUL HALAWA, M.D.'s specialty?
ABDUL HALAWA, M.D. specializes in Infectious Disease Physician and practices in CHARDON, Ohio. Credentials: M.D..
How much does ABDUL HALAWA, M.D. prescribe under Medicare Part D?
In 2023, ABDUL HALAWA, M.D. wrote 249 Medicare Part D claims totaling $15K in drug costs for 40 beneficiaries.
Where is ABDUL HALAWA, M.D. located?
ABDUL HALAWA, M.D. is located at 13170 RAVENNA RD, CHARDON, OH, 44024. Phone: (440) 739-0420.
What is ABDUL HALAWA, M.D.'s NPI number?
ABDUL HALAWA, M.D.'s National Provider Identifier (NPI) is 1003813262, issued on 07/03/2005.
Does ABDUL HALAWA, M.D. prescribe more brand-name or generic drugs?
ABDUL HALAWA, M.D.'s prescribing is 10% brand-name and 90% generic drugs by claim count, with $2K in brand drug costs.
How many Infectious Disease Physician providers are there in the US?
There are 8,292 Infectious Disease Physician providers across 54 states in the US. The average Infectious Disease Physician provider writes 816 Medicare Part D claims per year.
What drugs does ABDUL HALAWA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ABDUL HALAWA, M.D.'s most frequently prescribed drugs include Ceftriaxone, Furosemide, Vancomycin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ABDUL HALAWA, M.D. accept Medicare?
ABDUL HALAWA, M.D. appears in CMS Medicare data with 249 Part D claims and 40 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ABDUL HALAWA, M.D.'s credentials?
ABDUL HALAWA, M.D.'s NPI is 1003813262 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology